DiviDrip · RZLT

RZLT — Rezolute, Inc.

RZLT is Rezolute, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $4.54. Market cap: $439M. Capital Quality Rank: 40/100 — Stagnant mediocrity.

Stock snapshot

Price$4.54
Market cap$439M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)40 / 100 · Stagnant mediocrity
ROIC (TTM)-21.3%
Shareholder buyback yield-30.00%
Altman Z-score zoneSafe

About RZLT

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Listed2011Employees71HQRedwood City, CASectorHealthcareWebsiterezolutebio.com

Related non-dividend companies

Other non-dividend stocks investors research alongside RZLT. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is RZLT's current stock price?

RZLT (Rezolute, Inc.) is currently trading at $4.54.

Does RZLT pay a dividend?

RZLT (Rezolute, Inc.) does not currently pay a regular dividend.

What is RZLT's Capital Quality Rank?

RZLT has a Capital Quality Rank of 40/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track RZLT in DiviDrip

Add RZLT to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow